These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36103835)

  • 1. Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice.
    Kabbani M; Michailidis E; Steensels S; Fulmer CG; Luna JM; Le Pen J; Tardelli M; Razooky B; Ricardo-Lax I; Zou C; Zeck B; Stenzel AF; Quirk C; Foquet L; Ashbrook AW; Schneider WM; Belkaya S; Lalazar G; Liang Y; Pittman M; Devisscher L; Suemizu H; Theise ND; Chiriboga L; Cohen DE; Copenhaver R; Grompe M; Meuleman P; Ersoy BA; Rice CM; de Jong YP
    Cell Rep; 2022 Sep; 40(11):111321. PubMed ID: 36103835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.
    Ericson E; Bergenholm L; Andréasson AC; Dix CI; Knöchel J; Hansson SF; Lee R; Schumi J; Antonsson M; Fjellström O; Nasr P; Liljeblad M; Carlsson B; Kechagias S; Lindén D; Ekstedt M
    Hepatol Commun; 2022 Oct; 6(10):2689-2701. PubMed ID: 35833455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid droplet targeting of ABHD5 and PNPLA3 I148M is required to promote liver steatosis.
    Teskey G; Tiwari N; Butcko AJ; Kumar A; Yadav A; Huang YM; Kelly CV; Granneman JG; Perfield JW; Mottillo EP
    bioRxiv; 2024 Nov; ():. PubMed ID: 39605541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
    Engin A
    Adv Exp Med Biol; 2024; 1460():539-574. PubMed ID: 39287864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
    Baselli GA; Jamialahmadi O; Pelusi S; Ciociola E; Malvestiti F; Saracino M; Santoro L; Cherubini A; Dongiovanni P; Maggioni M; Bianco C; Tavaglione F; Cespiati A; Mancina RM; D'Ambrosio R; Vaira V; Petta S; Miele L; Vespasiani-Gentilucci U; Federico A; Pihlajamaki J; Bugianesi E; Fracanzani AL; Reeves HL; Soardo G; Prati D; Romeo S; Valenti LV;
    J Hepatol; 2022 Sep; 77(3):596-606. PubMed ID: 35405176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3.
    Gusdon AM; Hui Y; Chen J; Mathews CE; Qu S
    Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00187. PubMed ID: 33532620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
    Namjou B; Lingren T; Huang Y; Parameswaran S; Cobb BL; Stanaway IB; Connolly JJ; Mentch FD; Benoit B; Niu X; Wei WQ; Carroll RJ; Pacheco JA; Harley ITW; Divanovic S; Carrell DS; Larson EB; Carey DJ; Verma S; Ritchie MD; Gharavi AG; Murphy S; Williams MS; Crosslin DR; Jarvik GP; Kullo IJ; Hakonarson H; Li R; ; Xanthakos SA; Harley JB
    BMC Med; 2019 Jul; 17(1):135. PubMed ID: 31311600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers.
    McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT
    Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction Between PNPLA3 and SIRT5 Genetic Variants in Association with Liver Fibrosis Severity in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Moonlisarn K; Somnark P; Boonkaew B; Bunchorntavakul C; Tangkijvanich P
    Genes (Basel); 2024 Oct; 15(11):. PubMed ID: 39596570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
    Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hispanic Black Persons With Nonalcoholic Fatty Liver Disease Have Lower Rates of Advanced Fibrosis, Cirrhosis, and Liver-Related Events Even After Controlling for Clinical Risk Factors and PNPLA3 Genotype.
    Samala N; Xin Y; Wilson LA; Yates K; Loomba R; Hoofnagle JH; Chalasani N;
    Am J Gastroenterol; 2024 Sep; 119(9):1857-1865. PubMed ID: 38483303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes derived from diabetic microenvironment-preconditioned mesenchymal stem cells ameliorate nonalcoholic fatty liver disease and inhibit pyroptosis of hepatocytes.
    Wang A; Li B; Su W; Zhang H; Hu R; Zhang Y; Zhao J; Ren R; Mu Y; Cheng Y; Lyu Z
    Exp Cell Res; 2024 Dec; 443(2):114325. PubMed ID: 39521106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting PNPLA3 to Treat MASH and MASH Related Fibrosis and Cirrhosis.
    Lindén D; Tesz G; Loomba R
    Liver Int; 2024 Nov; ():. PubMed ID: 39605307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes.
    Barata L; Feitosa MF; Bielak LF; Halligan B; Baldridge AS; Guo X; Yerges-Armstrong LM; Smith AV; Yao J; Palmer ND; VanWagner LB; Carr JJ; Chen YI; Allison M; Budoff MJ; Handelman SK; Kardia SLR; Mosley TH; Ryan K; Harris TB; Launer LJ; Gudnason V; Rotter JI; Fornage M; Rasmussen-Torvik LJ; Borecki IB; O'Connell JR; Peyser PA; Speliotes EK; Province MA
    Hepatol Commun; 2019 Jul; 3(7):894-907. PubMed ID: 31334442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Onset of Steatosis Occurs as Early as Seven Days and Progresses to Nonalcoholic Steatohepatitis in a Pediatric Pig Model of Nonalcoholic Fatty Liver Disease.
    Yadav R; Gerrard SD; Lima MRM; Southard TL; Sunny NE; El-Kadi SW
    J Nutr; 2024 Nov; ():. PubMed ID: 39536967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS.
    Triana L; Palacios Huatuco RM; Campilgio G; Liscano E
    Aesthetic Plast Surg; 2024 Oct; 48(20):4217-4227. PubMed ID: 39103642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.